Celldex Therapeutics, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 44.68%74.19%1.58%3.81%43.23%
EBT Margin -244.10%-5.41%-483.53%-527.79%-1,983.70%-3,292.81%-2,321.11%-1,894.05%-920.61%-1,593.09%-1,423.96%-821.61%-1,520.92%-4,765.59%-2,054.76%-2,248.76%
EBIT Margin -242.75%-13.79%-468.42%-518.45%-1,981.08%-3,414.11%-2,363.89%-1,958.68%-953.68%-1,640.13%-1,540.19%-854.06%-1,531.78%-4,889.01%-2,245.27%-2,778.89%
EBITDA Margin -242.75%-13.79%-468.42%-518.45%-1,981.08%-3,294.98%-2,326.28%-1,890.60%-729.88%-1,584.87%-1,422.95%-806.28%-1,530.98%-4,792.49%-2,025.00%-2,248.68%
Operating Margin -242.75%-13.79%-468.42%-518.45%-1,981.08%-3,414.11%-2,363.89%-1,958.68%-953.68%-1,640.13%-1,540.19%-854.06%-1,531.78%-4,889.01%-2,245.27%-2,778.89%
Net Margin -240.61%-5.41%-483.53%-527.79%-1,983.70%-3,292.81%-2,321.11%-1,894.05%-730.06%-1,585.07%-1,423.96%-805.88%-1,516.04%-4,765.59%-2,054.76%-2,249.29%
FCF Margin -200.24%-69.39%-390.36%-447.11%-1,748.67%-2,885.28%-1,893.49%-1,706.26%-798.23%-797.32%-1,319.51%-565.60%-1,336.44%-4,478.57%-1,585.20%-2,275.20%
Efficiency
Assets Average 103.97M111.77M236.32M297.55M292.80M360.47M349.49M235.72M139.37M179.39M340.25M398.69M409.18M628.98M
Equity Average 74.51M71.99M82.25M207.78M265.73M250.88M277.77M250.90M180.21M109.04M151.69M314.42M372.84M377.69M588.09M
Invested Capital 73.77M87.67M74.86M101.37M319.80M211.66M290.11M265.43M236.37M124.06M94.03M209.36M419.48M326.20M429.17M747.00M
Asset Utilization Ratio 0.090.100.020.010.020.020.040.040.030.040.010.010.020.01
Leverage & Solvency
Interest Coverage Ratio -81.53-4.83-24.16-36.85-87.86
Debt to Equity 0.280.220.12
Debt Ratio 0.190.150.09
Equity Ratio 0.680.700.760.920.850.860.690.750.800.760.890.940.920.920.94
Times Interest Earned -81.53-4.83-24.16-36.85-87.86
Valuation
Enterprise Value 90.58M65.84M61.47M909.02M2,042.55M1,433.96M1,256.88M168.64M246.77M-59.89M-28.41M498.79M989.13M1,794.29M1,450.90M951.24M
Market Capitalization 147.58M126.94M114.78M992.98M2,345.54M1,635.00M1,546.76M358.42M386.20M34.13M35.97M693.21M1,397.38M2,099.24M1,874.50M1,676.52M
Return Ratios
Return on Sales -2.41%-0.05%-4.84%-5.28%-19.84%-32.93%-23.21%-18.94%-7.30%-15.85%-14.24%-8.06%-15.16%-47.66%-20.55%-22.49%
Return on Capital Employed -0.48%-0.62%-0.38%-0.45%-0.49%-0.41%-0.38%-0.70%-0.43%-0.38%-0.22%-0.30%-0.41%-0.33%
Return on Invested Capital -0.38%-0.86%-0.41%-0.23%
Return on Assets -0.43%-0.53%-0.35%-0.40%-0.43%-0.36%-0.27%-0.64%-0.37%-0.33%-0.21%-0.28%-0.35%-0.25%
Return on Equity -0.03%-0.62%-0.72%-0.39%-0.44%-0.51%-0.46%-0.37%-0.84%-0.47%-0.39%-0.22%-0.30%-0.37%-0.27%